Cargando…
Engineering human stellate cells for beta cell replacement therapy promotes in vivo recruitment of regulatory T cells
Type 1 diabetes (T1D) is an autoimmune disease characterized by destruction of pancreatic β cells. One of the promising therapeutic approaches in T1D is the transplantation of islets; however, it has serious limitations. To address these limitations, immunotherapeutic strategies have focused on rest...
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061575/ https://www.ncbi.nlm.nih.gov/pubmed/32159143 http://dx.doi.org/10.1016/j.mtbio.2019.100006 |